Insights

Loading spinner
Gathering insights about Design Pharmaceuticals Inc.

Similar companies to Design Pharmaceuticals Inc.

Design Pharmaceuticals Inc. Tech Stack

Design Pharmaceuticals Inc. uses 8 technology products and services including jQuery CDN, WordPress, Cloudflare, and more. Explore Design Pharmaceuticals Inc.'s tech stack below.

  • jQuery CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • Cloudflare
    Content Management System
  • CIVIC
    Cookie Compliance
  • Floating UI
    Javascript Libraries
  • Animate.css
    UI Frameworks
  • Magnific Popup
    Web Tools And Plugins
  • easy pie chart
    Web Tools And Plugins

Media & News

Design Pharmaceuticals Inc.'s Email Address Formats

Design Pharmaceuticals Inc. uses at least 1 format(s):
Design Pharmaceuticals Inc. Email FormatsExamplePercentage
F.Last@designpharmaceuticals.comJ.Doe@designpharmaceuticals.com
46%
FirstL@designpharmaceuticals.comJohnD@designpharmaceuticals.com
4%
F.Last@designpharmaceuticals.comJ.Doe@designpharmaceuticals.com
46%
FirstL@designpharmaceuticals.comJohnD@designpharmaceuticals.com
4%

Frequently Asked Questions

What is Design Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s official website is designpharmaceuticals.com and has social profiles on LinkedInCrunchbase.

What is Design Pharmaceuticals Inc.'s NAICS code?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Design Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Design Pharmaceuticals Inc. has approximately 11 employees across 1 continents, including North America. Key team members include Board Member: R. N.. Explore Design Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Design Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Design Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s tech stack includes jQuery CDNWordPressCloudflareCIVICFloating UIAnimate.cssMagnific Popupeasy pie chart.

What is Design Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Design Pharmaceuticals Inc.'s email format typically follows the pattern of F.Last@designpharmaceuticals.com. Find more Design Pharmaceuticals Inc. email formats with LeadIQ.

How much funding has Design Pharmaceuticals Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Design Pharmaceuticals Inc. has raised $5M in funding. The last funding round occurred on Apr 12, 2022 for $5M.

Design Pharmaceuticals Inc.

Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees

Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Our goal is to enable new treatments for patients suffering from diseases for which there are no satisfactory therapies.

GPCRs are the most common drug targets across all disease areas and account for approximately 30% of the therapeutic market. However, this market addresses only ca. 10% of all GPCRs. The advantage of our platform lies in our ability to harness broad and ultra-deep GPCR functional screening unlocking the blue sky to make novel therapeutics. Our platform technology is modality agnostic, ie screening small molecules, peptides, or antibody libraries. The assays can be run as agonist or antagonist assays, but most importantly, they identify hit candidates at an unprecedented scale and efficiency, increasing throughput 300-fold and reducing compound need 1000-fold. This is made possible by our unique cell-based multiplex GPCR screening platform, which enables the pooling of more than 300 cell lines representing hundreds of different GPCR drug targets, as our readout technology is based on NGS. This enables quantitative analysis of drug target function triggered by compounds while identifying potential off-target effects on other GPCR drug targets. At the same time, the platform is very flexible and can be adapted to include GPCR variants such as isoforms or mutant GPCR variants for drug function assays or SAR. Our discovery engine is complemented with cell-free synthesis for compound SAR and biologics libraries.

As a leading expert in droplet microfluidics, we are developing the future of GPCR screening. This will enable us to screen large complex libraries for hit candidates in millions of parallel assays and replace today's industry standard binding and affinity assays with deep exploration of drug space based on drug function assays in living cells.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5M

    Design Pharmaceuticals Inc. has raised a total of $5M of funding over 1 rounds. Their latest funding round was raised on Apr 12, 2022 in the amount of $5M.

  • $1M

    Design Pharmaceuticals Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $5M

    Design Pharmaceuticals Inc. has raised a total of $5M of funding over 1 rounds. Their latest funding round was raised on Apr 12, 2022 in the amount of $5M.

  • $1M

    Design Pharmaceuticals Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.